Jazz Pharmaceuticals JAZZ Payments To Acquire Other Productive Assets
Payments To Acquire Other Productive Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherProductiveAssets.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's payments to acquire other productive assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's payments to acquire other productive assets?
- Jazz Pharmaceuticals (JAZZ) reported payments to acquire other productive assets of $77.2M in Q1 2026.